Pricing Log in Create free account

PDS Biotechnology Corporation (PDSB) vs Protara Therapeutics, Inc. (TARA)

PDS Biotechnology Corporation and Protara Therapeutics, Inc. are both Biotechnology companies. PDS Biotechnology Corporation and Protara Therapeutics, Inc. are of similar size ($135.9M and $129.2M). Across the 9 metrics below, PDS Biotechnology Corporation leads on 5 and Protara Therapeutics, Inc. on 4.

Valuation

Metric PDSB TARA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m 0.87 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.02 0.66
EV/Sales n/m n/m 9.02
Earnings yield (52.03%) (58.70%) (32.88%)
Free cash flow yield (24.15%) (47.40%) (23.13%)

Profitability

Metric PDSB TARA Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (543.97%) (45.80%) (51.96%)
Return on assets (136.65%) (42.05%) (46.06%)
Return on invested capital 0.00% (255.06%) 0.00%

Growth

Metric PDSB TARA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 28.16% 38.25% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PDSB TARA Biotechnology median
Debt to equity (1.21) 0.00 0.00
Current ratio 0.57 10.97 4.97
Net debt to EBITDA 0.50 2.38 1.01

Dividend

Metric PDSB TARA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PDSB TARA Biotechnology median
Market cap 129.16m 135.92m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack